OncoSec Medical Inc. Appoints Jean S. Campbell, Ph.D. As Executive Director Of Research And Development
4/21/2014 6:13:53 AM
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, has appointed Jean S. Campbell, Ph.D. as Executive Director of Research and Development, a newly created position. Dr. Campbell, an Associate Professor in the Department of Pathology in the School of Medicine at the University of Washington, Seattle, will leverage her considerable expertise in cancer biology and signal transduction to investigate mechanisms of immune tolerance in cancer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by